Jeffrey Cleland is the founder of Ashvattha Therapeutics. Latest round: Series B. Backed by Tribe Capital, Arjun Sethi. Based in San Mateo, California.
Jeffrey L. Cleland, PhD, is the President and CEO of Ashvattha Therapeutics, a biotechnology company focused on nanomedicine therapies for ocular diseases. He has significant startup experience, having secured over $500 million in capital across various funding stages, including an IPO exit.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide